Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will report financial results for the fourth quarter and full year 2012 on Thursday, March 7, 2013, after market close. Company management will host a conference call at 5:00 pm Eastern on March 7, 2013 to discuss the financial results for the fourth quarter and full twelve months of 2012, recent business developments, revenue guidance for the first quarter of 2013 and revenue and net income guidance for full year 2013. The conference call will be accessible by dialing 888/679-8038 or 617/213-4850 (international) and providing passcode 76232628. A webcast of the conference call will be accessible from the company’s website at www.emergentbiosolutions.com, under “Investors”. Emergent BioSolutions is offering call participants a pre-registration option that expedites access to the call and minimizes hold times. Pre-registrants will be issued a pin number to be used when dialing into the live call which will provide quick access to the conference call by bypassing the operator upon connection. Pre-registration, while not mandatory, can be accessed using the following website: https://www.theconferencingservice.com/prereg/key.process?key=PQUQKA7V3. A replay of the conference call will be accessible, approximately two hours following the conclusion of the call, by dialing 888/286-8010 or 617/801-6888 and using the passcode 28122043. The replay will be available through March 21, 2013. The webcast will be archived on the company’s website, www.emergentbiosolutions.com, under “ Investors”. About Emergent BioSolutions Inc. Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com. Follow us on twitter: @emergentbiosolu.